To view this email as a web page, click here

   Home

Subscribe

Advertise

 

 

 

 

July 23, 2019___

Today's Rundown

Featured Story

Frequency bags $62M to advance Astellas-partnered hearing loss drug

Frequency Therapeutics has raised $62 million to take its Astellas-partnered hearing loss drug into phase 2a. The series C is the latest in a series of boosts for Frequency’s attempts to tackle hearing loss through the activation of progenitor cells. 

Top Stories

Myovant's uterine fibroid med hits the mark in 2nd phase 3 trial

Myovant’s uterine fibroid drug relugolix reduced blood loss in nearly three-quarters of patients, trouncing placebo in the second of two phase 3 studies. The company plans to file for FDA approval in the fourth quarter.

Proteostasis nabs Belous from Galapagos for cystic fibrosis push

Proteostasis Therapeutics has named former Galapagos scientist Andrey Belous as its senior medical director. The cystic fibrosis biotech unveiled Belous’ appointment alongside news of the promotion of Geoff Gilmartin to the CMO position.

Gilead's long-acting HIV med cuts viral load in phase 1b

HIV researchers have spent years looking into the capsid that protects the virus’ genetic material. Now, Gilead is posting the first clinical evidence that a drug targeting this shell can become part of the arsenal to treat people with HIV.

The first 3D models of Parkinson's, MS are headed into space

A group of brain organoids are set to blast off to the International Space Station Wednesday, the first to model Parkinson’s disease and multiple sclerosis in microgravity.

Sanofi grabs nonprescription rights to Roche's Tamiflu, aiming for Rx-to-OTC switch

Roche hopes Xofluza can pick up flu sales lost to Tamiflu generics. But it might end up competing with over-the-counter Tamiflu, too. Sanofi has snapped up Tamiflu's OTC rights in the U.S.

Resources

[Whitepaper] The Truth about Physician Referrals and Clinical Trials

The Study Voices survey challenges the myth that physicians won’t refer patients to clinical trials, and it identifies opportunities to engage physicians as partners in the enrollment process.

[eBook] Small molecules 2.0: the bigger picture

The highest number of NCEs approved by the FDA…the fastest growing small molecule clinical pipeline reported in 20 years…these are exciting times for our industry.

[Paid Marketplace] Faster Research. Smarter Bibliographies.

Cut your research time in half - with an easy-to-use app for scientists that combines full-featured reference management with integrated search and on-demand document delivery.

[Video] Almac Launches Almac Adapt™ - a New Patient-Centric Supply Solution

Innovative Just in Time Manufacturing solution enables sponsors full late stage customisation of clinical trial materials

[Video] PwC Webcast: Goodbye cost shifting, hello employer activism

How are employer activism strategies beginning to replace the cost-sharing of the past, and improve the health of the workforce?

[Whitepaper] Transforming the future of medical shipments

The combination of SAVSU technology with United Airlines’ global network has made it easier than ever to bring cell and gene therapies to destinations beyond major markets.

[Whitepaper] IoT Technologies & Informatics Integration in Pharmaceuticals

Find out in this article how your pharmaceutical organization can leverage IoT technologies and informatics integration to innovate and improve overall operational efficiencies.

[Whitepaper] Managing Demand Uncertainty in Biologics Production

When a biologics company prepares to launch a new product, it must forecast the manufacturing capacity it will need. Learn more here.

[Report] NEW Report on 2019 e-Prescribing Regulations and Potential Impact

Patient demand for more information on their care is driving new e-prescribing regulations, and technology is evolving to help providers meet them. This report provides an overview of key areas where such regulation has emerged, and what it could mean for providers and healthcare IT companies.

[Whitepaper] Characterizing Drug Substance Properties Early Can Optimize Drug Product Formulation

Anticipate challenges in formulation early.

[Whitepaper] Managing Comorbidities in Type 2 Diabetes – Real World Evidence for Change

Patients living with diabetes deserve better – Real-World Evidence for effecting/realizing change in the management of type 2 diabetes and cardiovascular/renal comorbidities.

[Case Study] Clinical Supply Management

Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study.

[Video] Demand Led Services and Clinical Supply Efficiency

Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels.

[eBook] Strategies for Efficient Clinical Supply Management and Forecasting

Download the eBook to explore a proactive approach for clinical supply management.

Events